Literature DB >> 10861462

Projections of alcohol- and tobacco-related cancer mortality in Central Europe.

I Bray1, P Brennan, P Boffetta.   

Abstract

Central European mortality rates for cancer sites related to tobacco and alcohol have increased rapidly in recent decades. From a public health point of view, it is of considerable interest to know whether these past increases in cancer mortality will continue into the future. Cancer mortality rates for the period 1965-1994 in Bulgaria, Czech Republic and Slovakia (analysed together), Hungary, Poland, and Romania were analysed for cancers of the larynx, oral cavity and pharynx, oesophagus, bladder, kidney, and pancreas. Using a Bayesian age-period-cohort approach, we have calculated smoothed observed rates. The effects of period and cohort were extrapolated to estimate mortality projections for 1995-99, 2004-09, and 2005-09. Mortality rates for all sites are projected to increase in most countries. Hungary has the highest projected rates for most sites, and particularly rapid increases are expected for cancers of the oral cavity and pharynx and of the larynx in Hungarian men. The smoothed 1990-94 male mortality rates for these two sites of 16. 32/100,000 and 8.70/100,000, respectively, are projected to reach 35. 17/100,000 for cancer of the oral cavity and pharynx and 14.12/100, 000 for cancer of the larynx by the period 2000-04. For kidney cancer, former Czechoslovakia has the highest observed and projected mortality rates. The smoothed 1990-94 rate of 8.37/100,000 is expected to increase 24% to 10.38/100,000 by 2000-04. Our results indicate that further increases may be expected on top of the already high cancer mortality levels in Central Europe. Policies to reduce alcohol consumption and prevent smoking in younger generations are necessary to reduce mortality as these cohorts age. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10861462     DOI: 10.1002/1097-0215(20000701)87:1<122::aid-ijc18>3.0.co;2-w

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  19 in total

1.  Bladder cancer mortality in the Epirus district population (Greece).

Authors:  D Baltogiannis; A Tasos; G Voutsinas; H Dauaher; P Chambilomatis; X Giannakopoulos
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

2.  MAGE-A antigens in lesions of the oral mucosa.

Authors:  Eva Krauss; Stephan Rauthe; Stefan Gattenlöhner; Tobias Reuther; Michael Kochel; Ulrike Kriegebaum; Alexander C Kübler; Urs D A Müller-Richter
Journal:  Clin Oral Investig       Date:  2010-02-20       Impact factor: 3.573

3.  Disparities in oral and pharyngeal cancer incidence, mortality and survival among black and white Americans.

Authors:  Douglas E Morse; A Ross Kerr
Journal:  J Am Dent Assoc       Date:  2006-02       Impact factor: 3.634

4.  Association between tea and coffee consumption and risk of laryngeal cancer: a meta-analysis.

Authors:  Zhiguo Ouyang; Zhaoyan Wang; Jian Jin
Journal:  Int J Clin Exp Med       Date:  2014-12-15

5.  PRR4: A novel downregulated gene in laryngeal cancer.

Authors:  Seda Ekizoglu; Turgut Ulutin; Jalal Guliyev; Nur Buyru
Journal:  Oncol Lett       Date:  2018-01-29       Impact factor: 2.967

6.  Increase of hypophyseal hormone levels in male head and neck cancer patients.

Authors:  Eva Remenár; Irén Számel; Barna Budai; Borbála Vincze; István Gaudi; Sarolta Gundy; Miklós Kásler
Journal:  Pathol Oncol Res       Date:  2007-12-25       Impact factor: 3.201

7.  Analysis of primary risk factors for oral cancer from select US states with increasing rates.

Authors:  Anthony Bunnell; Nathan Pettit; Nicole Reddout; Kanika Sharma; Susan O'Malley; Michelle Chino; Karl Kingsley
Journal:  Tob Induc Dis       Date:  2010-02-23       Impact factor: 2.600

8.  Perception on the Relationship between Cancer and Usage of Tobacco and Alcohol in Hail, Saudi Arabia.

Authors:  Ibrahim Abdelmageed Ginawi
Journal:  J Clin Diagn Res       Date:  2013-09-17

9.  GSTM1 null genotype is a risk factor for laryngeal cancer.

Authors:  Xuejun Liu; Qijun Fan; Liyan Ni; Fanli Liu; Saiyu Huang; Jinjian Gao; Bobei Chen
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 10.  Cancer stem cells as targets for cancer therapy: selected cancers as examples.

Authors:  Sabine Hombach-Klonisch; Ted Paranjothy; Emilia Wiechec; Paola Pocar; Tarek Mustafa; Anja Seifert; Christian Zahl; Klaus Luis Gerlach; Katharina Biermann; Klaus Steger; Cuong Hoang-Vu; Klaus Schulze-Osthoff; Marek Los
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2008-05-30       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.